ACXP - צמיחת הכנסות ב-12 חודשים נגררים acurxpharma.com

סמל מסחרי של Acurx Pharmaceuticals Inc. (ACXP)

Acurx Pharmaceuticals (ACXP) is developing advanced gastrointestinal antibiotics that preserve beneficial microflora and is implementing software robots for clinical data analysis. However, a narrow focus on combating C. difficile and competition from generics create risks. The relative sales growth over a 12-month period compared to last year confirms these trends, and the value of 0.00 reflects the balance of the current revenue metric.

צמיחת מכירות משנה לשנה (TTM): Acurx Pharmaceuticals Inc. (ACXP) עבור 11.02.2024 - 18.11.2026

Acurx Pharmaceuticals Inc. - פילוחים אנליטיים ומדדי מפתח (ACXP)

- מחיר מניה ומחיר יעד קונצנזוס:
ניתוח כל מדדי החברה:Acurx Pharmaceuticals Inc.
מוצר סדרתי של Acurx Pharmaceuticals, Inc.

To build a high-quality portfolio, I use this indicator as a tool to measure the rolling year revenue expansion rate on a daily basis. This model eliminates quarterly gaps, allowing for a comparison of current revenues with the same period last year, which is critical for Acurx Pharmaceuticals (ACXP), as its clinical trial costs are growing faster than operating revenue, reflecting a lack of scaling leverage in the annual dynamics of sales proceeds over four quarters.